Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ISRCTN17314414) titled 'Glutathione absorption and health outcomes study' on Oct. 9.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: RDC Global
Condition:
Adults with poor diet and/or regular alcohol intake
Nutritional, Metabolic, Endocrine
Intervention:
Participants are randomised 1:1 using computer-generated randomisation (sealedenvelope.com), with sequential numbered product assignment to the below treatments:
- Active arm: Oral liposomal glutathione 500 mg (4 mL liquid), once daily for 8 we...